Liabilities, Current in USD of Immunome Inc. from Q4 2019 to Q3 2025

Taxonomy & unit: us-gaap: USD
Description: Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.
Summary: Immunome Inc. quarterly Liabilities, Current history and change rate from Q4 2019 to Q3 2025.
Immunome Inc. Liabilities, Current for the quarter ending 30 Sep 2025 was $31.4M, a 20.4% decline year-over-year.

Liabilities, Current, Quarterly (USD)

Liabilities, Current, YoY Quarterly Change (%)

Immunome Inc. Quarterly Liabilities, Current (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q3 2025	$31.4M	-$8.08M	-20.4%	30 Sep 2025	10-Q	06 Nov 2025
Q2 2025	$22.9M	-$17M	-42.7%	30 Jun 2025	10-Q	06 Aug 2025
Q1 2025	$30.8M	+$29K	+0.09%	31 Mar 2025	10-Q	12 May 2025
Q4 2024	$54.3M	+$32.5M	+149%	31 Dec 2024	10-Q	06 Nov 2025
Q3 2024	$39.5M	+$16.4M	+71%	30 Sep 2024	10-Q	13 Nov 2024
Q2 2024	$39.9M	+$13.5M	+51.2%	30 Jun 2024	10-Q	12 Aug 2024
Q1 2024	$30.8M	+$5.94M	+23.9%	31 Mar 2024	10-Q	14 May 2024
Q4 2023	$21.8M	+$14.5M	+198%	31 Dec 2023	10-K	19 Mar 2025
Q3 2023	$23.1M	+$15.7M	+214%	30 Sep 2023	10-Q	09 Nov 2023
Q2 2023	$26.4M	+$17.8M	+206%	30 Jun 2023	10-Q	09 Aug 2023
Q1 2023	$24.8M	+$15.1M	+156%	31 Mar 2023	10-Q	05 May 2023
Q4 2022	$7.33M	-$2.4M	-24.6%	31 Dec 2022	10-K	28 Mar 2024
Q3 2022	$7.37M	-$396K	-5.1%	30 Sep 2022	10-Q	14 Nov 2022
Q2 2022	$8.62M	+$5.1M	+145%	30 Jun 2022	10-Q	05 Aug 2022
Q1 2022	$9.71M	+$5.14M	+112%	31 Mar 2022	10-Q	12 May 2022
Q4 2021	$9.73M	+$6.69M	+220%	31 Dec 2021	10-K	16 Mar 2023
Q3 2021	$7.77M	+$2.36M	+43.6%	30 Sep 2021	10-Q	15 Nov 2021
Q2 2021	$3.52M			30 Jun 2021	10-Q	16 Aug 2021
Q1 2021	$4.57M			31 Mar 2021	10-Q	12 May 2021
Q4 2020	$3.04M	+$1.37M	+82.5%	31 Dec 2020	10-K	28 Mar 2022
Q3 2020	$5.41M			30 Sep 2020	10-Q	16 Nov 2020
Q4 2019	$1.67M			31 Dec 2019	10-K	25 Mar 2021

* An asterisk sign (*) next to the value indicates that the value is likely invalid.